retatrutide eli lilly press release 2024 2025 https://investor.lilly.com/news-releases/news-release-details/zepbound-tirzepatide-most-prescribed-weight-management “Eli and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved a label expansion for Zepbound Lilly's Orforglipron, Retatrutide Named as

S5A), suggesting that the deletion of Gclc was localized to the liver

Delayed gastric emptying: As a class effect, incretin agents slow gastric emptying, which may affect the absorption of orally administered medicines

(6) M H Rasmussen, J Frystyk, T Andersen, L Breum, et al (1994) The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone Metabolism, 1994 Mar, Volume 43 (Issue 3), Pages 315-9

Being in a liposomal form will allow the liquid that is swallowed to bypass the harsh environment of the stomach to allow continued absorption of the glutathione in the intestines